Candidate driver genes in microsatellite‐unstable colorectal cancer

Defects in the mismatch repair system lead to microsatellite instability (MSI), a feature observed in ∼ 15% of all colorectal cancers (CRCs). Microsatellite mutations that drive tumourigenesis, typically inactivation of tumour suppressors, are selected for and are frequently detected in MSI cancers. Here, we evaluated somatic mutations in microsatellite repeats of 790 genes chosen based on reduced expression in MSI CRC and existence of a coding mononucleotide repeat of 6–10 bp in length. All the repeats were initially sequenced in 30 primary MSI CRC samples and whenever frameshift mutations were identified in >20%, additional 70 samples were sequenced. To distinguish driver mutations from passengers, we similarly analyzed the occurrence of frameshift mutations in 121 intronic control repeats and utilized a statistical regression model to determine cut‐off mutation frequencies for repeats of all types (A/T and C/G, 6–10 bp). Along with several know target genes, including TGFBR2, ACVR2, and MSH3, six novel candidate driver genes emerged that harbored significantly more mutations than identical control repeats. The mutation frequencies in 100 MSI CRC samples were 51% in G8 of GLYR1, 47% in T9 of ABCC5, 43% in G8 of WDTC1, 33% in A8 of ROCK1, 30% in T8 of OR51E2, and 28% in A8 of TCEB3. Immunohistochemical staining of GLYR1 revealed defective protein expression in tumors carrying biallelic mutations, supporting a loss of function hypothesis. This is a large scale, unbiased effort to identify genes that when mutated are likely to contribute to MSI CRC development.

[1]  K. Kinzler,et al.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.

[2]  L. Loeb,et al.  A mutator phenotype in cancer. , 2001, Cancer research.

[3]  T. Ørntoft,et al.  Gene expression signatures for colorectal cancer microsatellite status and HNPCC , 2005, British Journal of Cancer.

[4]  R. Chadwick,et al.  Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Hollema,et al.  Do microsatellite instability profiles really differ between colorectal and endometrial tumors? , 2009, Genes, chromosomes & cancer.

[6]  Rainer Lehtonen,et al.  Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers. , 2005, Cancer research.

[7]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[8]  P. Johnston,et al.  The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites , 2005, Molecular Cancer Therapeutics.

[9]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[10]  Sampsa Hautaniemi,et al.  Mutations in the Circadian Gene CLOCK in Colorectal Cancer , 2010, Molecular Cancer Research.

[11]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[12]  L. Kasturi,et al.  Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Thomas,et al.  Differential nonsense mediated decay of mutated mRNAs in mismatch repair deficient colorectal cancers. , 2005, Human molecular genetics.

[14]  N. Matsubara,et al.  Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers. , 2002, Cancer research.

[15]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[16]  L. Hawthorn,et al.  Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells , 2007, Oncogene.

[17]  Darryl Shibata,et al.  Unregulated smooth-muscle myosin in human intestinal neoplasia , 2008, Proceedings of the National Academy of Sciences.

[18]  J C Reed,et al.  Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype , 1997, Science.

[19]  M. Ittmann,et al.  Increased expression of prostate‐specific G‐protein‐coupled receptor in human prostate intraepithelial neoplasia and prostate cancers , 2005, International journal of cancer.

[20]  H. Yamamoto,et al.  Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. , 1999, Cancer research.

[21]  Jiahuai Han,et al.  Nuclear protein NP60 regulates p38 MAPK activity , 2006, Journal of Cell Science.

[22]  Hiroyuki Yamamoto,et al.  Frameshift mutator mutations , 1996, Nature.

[23]  Jianjian Shi,et al.  Rho kinase in the regulation of cell death and survival , 2007, Archivum Immunologiae et Therapiae Experimentalis.

[24]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[25]  Yan P. Yuan,et al.  Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes , 2003, Oncogene.

[26]  M. Stratton,et al.  Somatic mutations in human cancer: insights from resequencing the protein kinase gene family. , 2005, Cold Spring Harbor symposia on quantitative biology.

[27]  I. Borecki,et al.  WDTC1, the Ortholog of Drosophila Adipose Gene, Associates With Human Obesity, Modulated by MUFA Intake , 2009, Obesity.

[28]  Peiqing Sun,et al.  The pathways to tumor suppression via route p38. , 2007, Trends in biochemical sciences.

[29]  Rainer Lehtonen,et al.  Background mutation frequency in microsatellite-unstable colorectal cancer. , 2007, Cancer research.

[30]  L. Aaltonen,et al.  Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. , 1998, The New England journal of medicine.

[31]  W. Grady Genomic instability and colon cancer , 2004, Cancer and Metastasis Reviews.

[32]  R. Sandler,et al.  Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers. , 2004, Gastroenterology.

[33]  M. Olson,et al.  Activating ROCK1 somatic mutations in human cancer , 2010, Oncogene.

[34]  L. Aaltonen,et al.  Population-based molecular detection of hereditary nonpolyposis colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.